Desmoplastic malignant melanoma: A study of ten cases and status of BRAF mutation

Dermatology

Volumn 225, Issue 2, 2012, Pages 168-171

  Coupelon, S ^a   Franck, F ^a   Jarrousse, A S ^a   Dechelotte P ^a   Souteyrand, P ^a   D'Incan, M ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

BRAF gene; Desmoplastic malignant melanoma; Neurotropism; V600E mutation

Indexed keywords

B RAF KINASE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; DESMOPLASTIC MELANOMA; FEMALE; HEAD; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MISSENSE MUTATION; NECK; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRUNK; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84870797362     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000342506     Document Type: Article

References (19)

1. Conley J, Lattes R, Orr W: Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971; 28: 914-936.
2. Quinn MJ, Crotty KA, Thompson JF, et al: Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998; 83: 1128-1135.
3. Reed RJ, Leonard DD: Neurotropic melanoma. A variant of desmoplastic melanoma. Am J Surg Pathol 1979; 3: 301-311.
4. Busam KJ, Mujumdar U, Hummer AJ, et al: Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol 2004; 28: 1518-1525.
5. Hawkins WG, Busam KJ, Ben-Porat L, et al: Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol 2005; 12: 207-213.
6. Scolyer RA, Thompson JF: Desmoplastic melanoma: a heterogeneous entity in which subclassification as 'pure' or 'mixed' may have important prognostic significance. Ann Surg Oncol 2005; 12: 197-199.
7. McCarthy SW, Scolyer RA, Palmer AA: Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology 2004; 36: 445-451.
8. Jaroszewski DE, Pockaj BA, DiCaudo DJ, Bite U: The clinical behavior of desmoplastic melanoma. Am J Surg 2001; 182: 590-595.
9. Pawlik TM, Ross MI, Prieto VG, et al: Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer 2006; 106: 900-906.
10. Busam KJ, Zhao H, Coit DG, et al: Distinction of desmoplastic melanoma from nondesmoplastic melanoma by gene expression profiling. J Invest Dermatol 2005; 124: 412-418.
11. Davison JM, Rosenbaum E, Barrett TL, et al: Absence of V599E BRAF mutations in desmoplastic melanomas. Cancer 2005; 103: 788-792.
12. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
13. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
14. Murali R, Shaw HM, Lai K, et al: Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer 2010; 116: 4130-4138.
15. Livestro DP, Muzikansky A, Kaine EM, et al: Biology of desmoplastic melanoma: a casecontrol comparison with other melanomas. J Clin Oncol 2005; 23: 6739-6746.
16. Chapman PB, Hauschild A, Robert C, et al: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-2516.
17. Davies H, Bignell GR, Cox C, et al: Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954.
18. Uribe P, Wistuba II, Gonzalez S: BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol 2003; 25: 365-370.
19. Maldonado JL, Fridlyand J, Patel H, et al: Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 1878-1890.